A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis.
Saved in:
| Title: | A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis. |
|---|---|
| Authors: | Maersk-Moller C; Department of Neurology, Multiple Sclerosis Clinic, Aarhus University Hospital, Aarhus N, Denmark.; Department of Biomedicine, Aarhus University, Aarhus C, Denmark., Pontieri L; Department of Neurology, The Danish Multiple Sclerosis Registry, Copenhagen University Hospital-Rigshospitalet Glostrup, Glostrup, Denmark., Stilund MLM; Department of Neurology, Physiotherapy and Occupational Therapy, Gødstrup Hospital, Herning, Denmark.; NIDO, Centre for Research and Education, Gødstrup Hospital, Herning, Denmark., Christensen JR; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Storr LK; Department of Neurology, Zealand University Hospital, Roskilde, Denmark., Hansen V; Department of Neurology, Aalborg University Hospital, Aalborg, Denmark., Schäfer J; Department of Neurology, Aalborg University Hospital, Aalborg, Denmark., Weglewski A; Department of Neurology, Copenhagen University Hospital, Herlev and Gentofte, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark., Romani KQ; Department of Neurology, Viborg Hospital, Viborg, Denmark., Jensen HB; Department of Neurology, Lillebaelt Hospital, Kolding, Denmark.; Department of Regional Health Research, University of Southern Denmark, Odense M, Denmark., Illes Z; Department of Neurology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Papp V; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark., Sejbaek T; Department of Neurology, University Hospital of Southern Denmark, Southwest Jutland Hospital, Esbjerg, Denmark.; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense M, Denmark., Poulsen MB; Department of Neurology, North Zealand Hospital, Copenhagen University Hospital, Hillerød, Denmark., Kant M; Department of Neurology, Hospital of Southern Jutland, University of Southern Denmark, Aabenraa, Denmark., Torring CW; Department of Neurology, Multiple Sclerosis Clinic, Aarhus University Hospital, Aarhus N, Denmark., Sellebjerg F; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark., Magyari M; Department of Neurology, The Danish Multiple Sclerosis Registry, Copenhagen University Hospital-Rigshospitalet Glostrup, Glostrup, Denmark.; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital - Rigshospitalet, Glostrup, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen N, Denmark. |
| Corporate Authors: | DMSG Group |
| Source: | European journal of neurology [Eur J Neurol] 2026 Feb; Vol. 33 (2), pp. e70507. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1468-1331 |
|---|---|
| DOI: | 10.1111/ene.70507 |
